Cargando…

An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids

BACKGROUND: Ovarian cancer (OC) is the most lethal gynecological cancer due to the recurrence of drug-resistance. Cancer initiating cells (CICs) are proposed to be responsible for the aggressiveness of OC. The rarity and difficulty of in vitro long-term cultivation of CICs challenge the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu-An, Lu, Chen-Yu, Cheng, Wen-Fang, Kuo, Kuan-Ting, Yu, Chen-Wei, Ho, Hon-Nerng, Chen, Hsin-Fu, Pan, Szu-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463800/ https://www.ncbi.nlm.nih.gov/pubmed/36085021 http://dx.doi.org/10.1186/s12885-022-10042-3

Ejemplares similares

The organoid: A research model for ovarian cancer
por: Chang, Yu-Hsun, et al.
Publicado: (2021)

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
por: Maenhoudt, Nina, et al.
Publicado: (2020)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Organoid of ovarian cancer: genomic analysis and drug screening
por: Liu, H.-D., et al.
Publicado: (2020)

Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study
por: Huang, Chen-Yu, et al.
Publicado: (2020)

Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
por: Hu, Yi, et al.
Publicado: (2023)

Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
por: Yang, Jiani, et al.
Publicado: (2021)

Protocol for establishing organoids from human ovarian cancer biopsies
por: Maenhoudt, Nina, et al.
Publicado: (2021)

Patient-Initiated Follow-Up in Ovarian Cancer
por: Luk, Hiu Mei, et al.
Publicado: (2023)

Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer
por: Ke, Feng‐Yi, et al.
Publicado: (2020)

Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
por: Chan, Wai Sun, et al.
Publicado: (2023)

Wound-site metastasis in laparotomy of ovarian cancer
por: Modi, Vijal, et al.
Publicado: (2017)

The impact of previous ovarian surgery on ovarian reserve in patients with endometriosis
por: Chiang, Hsin-Ju, et al.
Publicado: (2015)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
por: Koshiyama, Masafumi, et al.
Publicado: (2017)

Ovarian reserve in premenopausal women with breast cancer
por: Zong, Xiangyun, et al.
Publicado: (2022)

Dendritic Cell Vaccines in Ovarian Cancer
por: Zhang, Xi, et al.
Publicado: (2021)

ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells
por: Luo, N, et al.
Publicado: (2016)

Effects of Icodextrin Solution (Adept(®)) on Ovarian Cancer Cell Proliferation in an In Vitro Model
por: Chen, Wen-Hsin, et al.
Publicado: (2022)

YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2014)

YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistance in Ovarian Cancer Initiated Cells
por: Xia, Yan, et al.
Publicado: (2014)

Human pluripotent stem cell-derived DDX4 and KRT-8 positive cells participate in ovarian follicle-like structure formation
por: Yu, Danny C.W., et al.
Publicado: (2020)

The Value of the Stemness Index in Ovarian Cancer Prognosis
por: Yuan, Hongjun, et al.
Publicado: (2022)

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
por: Dumont, Sander, et al.
Publicado: (2019)

Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients
por: Lu, Hsiao-Yun, et al.
Publicado: (2020)

Correction: YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2016)

OVARIAN CANCER
Publicado: (1984)

Ovarian cancer
por: Kerbrat, P, et al.
Publicado: (2001)

Ovarian Cancer
por: Judson, I.
Publicado: (1993)

Ovarian Cancer
por: Song, Yong Sang, et al.
Publicado: (2014)

Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues
por: Gan, Meifu, et al.
Publicado: (2023)

Epidemiology and Mortality of Ovarian Cancer in Taiwan: A Population-Based Study
por: Teng, Yun-Hui, et al.
Publicado: (2022)

Ovulation and extra-ovarian origin of ovarian cancer
por: Yang-Hartwich, Yang, et al.
Publicado: (2014)

Endometriosis and Ovarian Cancer: an Integrative Review (Endometriosis and Ovarian Cancer)
por: Brilhante, Aline Veras Morais, et al.
Publicado: (2017)

Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model
por: Lu, Tzu-Pin, et al.
Publicado: (2019)

Targeting UDP‐glucose dehydrogenase inhibits ovarian cancer growth and metastasis
por: Lin, Li‐Hsun, et al.
Publicado: (2020)

Obesity alters ovarian folliculogenesis through disrupted angiogenesis from increased IL-10 production
por: Yang, Po-Kai, et al.
Publicado: (2021)

Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
por: Lin, Hao, et al.
Publicado: (2021)

Plate-like Alginate Microparticles with Disulfiram–SPIO–Coencapsulation: An In Vivo Study for Combined Therapy on Ovarian Cancer
por: Bai, Meng-Yi, et al.
Publicado: (2021)

Transcriptome sequencing identifies genes associated with invasion of ovarian cancer
por: Peng, Xiandong, et al.
Publicado: (2020)

The Role of Cancer-Associated Fibroblasts in Ovarian Cancer
por: Zhang, Mo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rl1g851ccaiqha01kr8afk1r4e